C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings

Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
11/2006
11/30/2006	DE102005038947A1 Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln Substituted benzo [d] isoxazol-3-yl-amine compounds and their use in medicaments
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	CN1869027A Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/23/2006	WO2006122949A1 Malononitriles and their use as pesticides
11/23/2006	WO2006122800A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	WO2006122799A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264487 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/23/2006	DE102005044814A1 New spiro-isoxazole-cycloalkane compounds, useful as vanilloid receptor 1 ligands for treating e.g. pain, depression and neurodegeneration
11/23/2006	CA2608773A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	CA2608386A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/22/2006	EP1724274A1 Polycyclic ketone compound and process for producing the same
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	CN1285572C Cannabinod receptor ligands
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/21/2006	CA2117413C Herbicidal isoxazole-4-yl-methanone derivatives
11/16/2006	US20060258725 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein
11/16/2006	US20060257987 Ppar modulators
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135489 Cyclooxygenase inhibitors; antiinflammatory agents
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/09/2006	US20060252647 Herbicides; broad active spectrum; on soil and above ground plant parts use
11/08/2006	EP1719767A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/07/2006	US7132001 Oxidative dye couplers; light, wash and rub fastness; storage stability; intense shades
11/05/2006	CA2545778A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/02/2006	WO2006116615A1 Benzisoxazole piperazine compounds and methods of use thereof
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247288 Method for manufacturing isoxazole derivative or dihydroisoxazole derivative
11/02/2006	US20060247287 Heterocyclic Anti-Viral Compounds Comprising Metabolizable Moieties And Their Uses
11/02/2006	US20060247260 Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	EP1717231A1 Substituted azole compounds and thereof preparation and application
11/02/2006	EP1716127A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	CA2606473A1 Benzisoxazole piperazine compounds and methods of use thereof
11/01/2006	CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
10/2006
10/31/2006	US7129259 Halogenated biaryl heterocyclic compounds and methods of making and using the same
10/31/2006	CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/26/2006	WO2006111321A1 Azole derivatives in the form of lipase and phospholipase inhibitors
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	US20060241157 Heterocyclic ppar modulators
10/26/2006	US20060241106 Isoxazole compounds as inhibitors of heat shock proteins
10/26/2006	US20060240475 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal
10/26/2006	DE102005018389A1 Azolderivate als Inhibitoren von Lipasen und Phospholipasen Azole derivatives as inhibitors of lipases and phospholipases
10/26/2006	CA2606301A1 Azole derivatives in the form of lipase and phospholipase inhibitors
10/25/2006	EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7125903 Drugs for treatment of obsessive compulsive disorder, cognitive activators, psychosis, parkinson's disease as antagonist
10/24/2006	US7125902 Anticancer agents for, lungs, leukemia and ovarian cancer or prostate glands
10/24/2006	US7125865 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds
10/19/2006	WO2006085212A3 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
10/19/2006	US20060235057 Phenyl compounds
10/18/2006	EP1711478A2 Benzo [d]isoxazol-3-ol daao inhibitors
10/18/2006	CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
10/18/2006	CN1847231A Process of preparing aromatic ring substituted ixooxazoline compound
10/18/2006	CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006	WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006	US20060229454 One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide
10/12/2006	CA2602467A1 Bcrp/abcg2 inhibitor
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1708700A1 Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
10/11/2006	EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
10/11/2006	CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors
10/10/2006	US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders
10/10/2006	US7119085 Inhibit amyloid protein deposits
10/05/2006	WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006	US20060223873 Isoxazole derivatives and methods of treating nitric oxide mediated diseases
10/05/2006	US20060223848 Caspase inhibitors containing isoxazoline ring
10/05/2006	US20060223784 Method and compositions for temporarily incapacitating subjects
10/04/2006	EP1706390A2 Isoxazole derivatives and their use as cyclooxygenase inhibitors
10/04/2006	EP1706387A1 Substituted heterocyclic amides having a fungicidal effect
10/04/2006	EP1706129A1 Drug therapy for celiac sprue
10/04/2006	EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006	CN1842521A Caspase inhibitors containing isoxazoline ring
10/04/2006	CN1842272A Hydrazone derivatives for combatting harmful insects and arachnids
10/04/2006	CN1277824C Piperazine derivatives
10/03/2006	US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives
10/03/2006	US7115752 Substituted cyclic compounds
10/03/2006	US7115750 Melanin concentrating hormone antagonist
10/03/2006	US7115642 Inhibits replication and/or proliferation of Hepatitis C virus (HCV)
10/03/2006	US7115545 5-Phenylcarbonyloxy-1-methyl-1H-pyrazol-4-yl)-(8-methyl-sulfonyl-3a,4-dihydro-3H-indeno[1,2-c]isoxazol-5-yl)methanone
10/03/2006	CA2249348C Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
09/2006
09/28/2006	WO2006101052A1 Novel acetylene derivative
09/28/2006	WO2006100479A1 Methods for the synthesis of heteroaromatic compounds
09/28/2006	WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/28/2006	WO2006044975A3 Compositions and their use as anti-tumor agents
09/28/2006	WO2005119315A3 Non-linear optically active molecules, their synthesis, and use
09/28/2006	WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
09/28/2006	US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same
09/28/2006	CA2602112A1 Sulfonyl containing compounds as cysteine protease inhibitors

1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 115